Bayer Corporation

Industry Veteran Chris Turner Joins Pivot Bio as Chief Commercial Officer

Retrieved on: 
Wednesday, May 1, 2024
University, Agriculture, Bayer Corporation, Agricultural science, Partnership, Bayer, FMC Corporation, Crop protection, AG, Growth, Head, Management

ST. LOUIS and BERKELEY, Calif., May 1, 2024 /PRNewswire/ -- Pivot Bio, a leading sustainable agriculture company, announced today the appointment of industry veteran Chris Turner as Chief Commercial Officer. In this executive role, Turner will lead the company's global growth agenda and commercial sales organization. He will be a member of Pivot Bio's executive leadership team, reporting to Chris Abbott, CEO.

Key Points: 
  • ST. LOUIS and BERKELEY, Calif., May 1, 2024 /PRNewswire/ -- Pivot Bio, a leading sustainable agriculture company, announced today the appointment of industry veteran Chris Turner as Chief Commercial Officer.
  • "Chris is a highly regarded, results-oriented leader in the ag industry, and we couldn't be more excited that he is joining our team," said Chris Abbott, CEO of Pivot Bio.
  • "With nearly three decades of industry experience, Chris has effectively led extensive global commercial, strategic and operational teams.
  • Turner joins Pivot Bio from Bayer Corporation, where he has served as Head of the U.S.

Bayer Crop Sciences selects One Network Enterprises to power its Logistics and Supply Chain Control Tower

Retrieved on: 
Tuesday, February 20, 2024
ONE, Agricultural science, NEO, ETAS, AI, Kowloon Tong, Supply chain, Supply, Seed, Crop protection, Ecosystem, Platform, Agriculture, Bayer Corporation

DALLAS, Feb. 20, 2024 /PRNewswire/ -- One Network Enterprises (ONE), the leading global provider of intelligent control towers and the Digital Supply Chain Network™, is pleased to announce that Bayer Crop Sciences, a division of Bayer Corporation, has selected ONE to provide their Supply Chain Control Tower. Bayer will join the Digital Supply Chain Network™ to take advantage of a large and growing ecosystem, bringing efficiency, reliability, agility, and predictability to their global supply chain operations.

Key Points: 
  • By improving the on-time arrival of raw materials, Bayer Crop Science expects to further improve productivity in its global supply chain ecosystem
    DALLAS, Feb. 20, 2024 /PRNewswire/ -- One Network Enterprises (ONE), the leading global provider of intelligent control towers and the Digital Supply Chain Network™, is pleased to announce that Bayer Crop Sciences, a division of Bayer Corporation, has selected ONE to provide their Supply Chain Control Tower.
  • Bayer will join the Digital Supply Chain Network™ to take advantage of a large and growing ecosystem, bringing efficiency, reliability, agility, and predictability to their global supply chain operations.
  • The Bayer Crop Science division is a world-leading agriculture enterprise with businesses in seeds, crop protection, and nonagricultural pest control.
  • Bayer has selected One Network to provide their AI-powered NEO Platform to enable end-to-end visibility to make better data-driven decisions across the Bayer Crop Science supply network.

Relativity Announces its Third Annual AI Visionaries List

Retrieved on: 
Monday, January 22, 2024
Fortune 500, ALSP, CIO, Bayer Corporation, BakerHostetler, AI

CHICAGO, Jan. 22, 2024 /PRNewswire/ -- Relativity, a global legal technology company, today announced its annual list of AI Visionaries. The list recognizes and celebrates individuals who have explored, promoted or experimented with AI in novel ways in legal applications.

Key Points: 
  • CHICAGO, Jan. 22, 2024 /PRNewswire/ -- Relativity , a global legal technology company, today announced its annual list of AI Visionaries .
  • The list recognizes and celebrates individuals who have explored, promoted or experimented with AI in novel ways in legal applications.
  • The AI Visionaries' accomplishments have laid the groundwork for an inspirational, AI-fueled future, and we look forward to celebrating them."
  • Spotlighting leaders from Fortune 500 companies and top Am Law firms, the 2024 AI Visionaries list features those who have experimented with AI technologies prior to recent increased industry adoption and encouraged the use of AI both within their organization and outside of it.

Relativity Announces its Third Annual AI Visionaries List

Retrieved on: 
Monday, January 22, 2024
Fortune 500, ALSP, CIO, Bayer Corporation, BakerHostetler, AI

CHICAGO, Jan. 22, 2024 /PRNewswire/ -- Relativity, a global legal technology company, today announced its annual list of AI Visionaries. The list recognizes and celebrates individuals who have explored, promoted or experimented with AI in novel ways in legal applications.

Key Points: 
  • CHICAGO, Jan. 22, 2024 /PRNewswire/ -- Relativity , a global legal technology company, today announced its annual list of AI Visionaries .
  • The list recognizes and celebrates individuals who have explored, promoted or experimented with AI in novel ways in legal applications.
  • The AI Visionaries' accomplishments have laid the groundwork for an inspirational, AI-fueled future, and we look forward to celebrating them."
  • Spotlighting leaders from Fortune 500 companies and top Am Law firms, the 2024 AI Visionaries list features those who have experimented with AI technologies prior to recent increased industry adoption and encouraged the use of AI both within their organization and outside of it.

IPS Appoints Jim Stephanou as New CEO

Retrieved on: 
Monday, June 5, 2023
Research, Architecture, Professional Services, Pharmaceutical, Commercial Building & Real Estate, Construction & Property, Science, Engineering, Biotechnology, Building Systems, Health, Consulting, Manufacturing, Pharmaceutical industry, Multimedia, Drexel University, Berkshire, Bayer Corporation, Pleasure, Growth, Merck, Merck & Co., Pharmaceutical industry in India, IPS, Management

View the full release here: https://www.businesswire.com/news/home/20230605005759/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230605005759/en/
    IPS is excited to announce the appointment of Jim Stephanou as its new Chief Executive Officer (CEO) to lead the company into its next phase of growth.
  • Before joining Merck, Mr. Stephanou held several leadership positions at Bayer Corporation and Lyondell Basell Industries for over two decades.
  • Mr. Stephanou will report to Dave Goswami, the Global CEO of IPS Enterprise.
  • When discussing the new CEO appointment for IPS Life Science, Mr. Goswami stated, “We are excited to have someone of Jim’s caliber to take on the CEO role.

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023

Retrieved on: 
Thursday, May 11, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Axys, Monoclonal antibody, US Foods, Interest, Crown Bioscience International, AbbVie, Quality of life, PDL, Rights, TKI, Research, NSCLC, Immunotherapy, Lung cancer, Forbes China Celebrity 100, Sale, Bayer Corporation, VEGF, Patient, Investment, EGFR, SMMT, Webcast, Knowledge, Entrepreneurship, PD-1, FDA, Woman, Summit, Collaboration, Phase, Compugen (company), Michelle, Pharmaceutical industry, Security (finance), Cryptocurrency, Management, Pfizer

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the first quarter ended March 31, 2023.

Key Points: 
  • Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the first quarter ended March 31, 2023.
  • The Collaboration and License Agreement with Akeso closed on January 17, 2023 after going effective following customary waiting periods.
  • In exchange for these rights, Summit committed to an upfront payment of $500 million, which was paid in two installments.
  • Operating cash outflow for the three month ended March 31, 2023 and 2022 was $13.1 million and $19.0 million, respectively.

Matthews International Corporation Announces Nomination of New Director

Retrieved on: 
Tuesday, January 17, 2023
Business administration, Ross School, University, Ross School of Business, University of Pittsburgh, Georgia State University, Marketing, Bayer Corporation, Art, Management

Dr. Richards currently serves as Executive Vice President of Specialty Films for Covestro Deutschland AG located in Dormagen, Germany.

Key Points: 
  • Dr. Richards currently serves as Executive Vice President of Specialty Films for Covestro Deutschland AG located in Dormagen, Germany.
  • She also held executive positions in strategic marketing and human resources and services during her time with Bayer Corporation.
  • The Board of Directors (the “Board”) believes Dr. Richards is well-qualified to serve as a director on the Company’s Board.
  • With her strong background, global perspective and expertise in international business, marketing, sales, and strategy, as well as human resources and people management, she will bring important assets to Matthews.

Neuronetics Announces Appointment of Joseph H. Capper to its Board of Directors

Retrieved on: 
Thursday, December 29, 2022
Mental health, Audit committee, Patient, University, Biotelemetry, VA-42 (U.S. Navy), West Chester University, Bayer Corporation, STIM, George Washington University, International finance, Management, Neuronetics

“Joe is well known and extremely well regarded in the med-tech community for his ability to advance company goals," said Rob Cascella, Chairman of the Board of Neuronetics.

Key Points: 
  • “Joe is well known and extremely well regarded in the med-tech community for his ability to advance company goals," said Rob Cascella, Chairman of the Board of Neuronetics.
  • Prior to Home Diagnostics, Joe was President and Chief Executive Officer of CCS Medical Inc., a private company.
  • Joe received his undergraduate degree in accounting from West Chester University and an MBA in International Finance from George Washington University.
  • “The accelerating decline of mental health in the wake of the pandemic makes Neuronetics’ technology more relevant than ever,” said Mr. Capper.

Kessler Topaz Meltzer & Check, LLP: Bayer Corporation to Pay $40 Million to Settle Whistleblower Claims Alleging Fraud in Marketing Three Drugs

Retrieved on: 
Friday, September 2, 2022
Legal, Professional Services, Bayer Corporation, Accusative case, Office of Inspector General, U.S. Department of Health and Human Services, Safety, False Claims Act, Government, LLP, Time, Hospital, Complaint, FCA, P.C, Fraud, U.S. Department of Defense Strategy for Operating in Cyberspace, Review, Contract, Travel, Pharmaceutical industry, Aprotinin, Counsel, Bayer, Carella

The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) announces today that Bayer Corporation (Bayer) has agreed to pay $40 million to resolve claims in two longstanding, whistleblower lawsuits alleging that Bayer violated anti-fraud laws in selling and promoting three drugs, Trasylol, Avelox and Baycol.

Key Points: 
  • The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) announces today that Bayer Corporation (Bayer) has agreed to pay $40 million to resolve claims in two longstanding, whistleblower lawsuits alleging that Bayer violated anti-fraud laws in selling and promoting three drugs, Trasylol, Avelox and Baycol.
  • In addition, Bayer agreed to pay a separate amount to resolve claims that it unlawfully retaliated against the whistleblower who raised her concerns to superiors.
  • The cases were brought under the False Claims Act by a former Bayer employee, on behalf of the United States and numerous states.
  • Kessler Topaz has represented the whistleblower since 2014, with the whistleblower and her counsel devoting extensive time and expense towards litigating these non-intervened cases.

Advantage Capital Hires Jeff Grass as Vice President of Communications and Stakeholder Engagement

Retrieved on: 
Wednesday, January 26, 2022
Other Professional Services, Other Communications, Finance, Marketing, Communications, Small Business, Accounting, Professional Services, Poaceae, Marketing, Organization, Bayer Corporation, Communication, Capital, Director of communications, Anheuser-Busch, Investment Advisers Act of 1940, LinkedIn, Twitter, Webster University, Management, St. Louis, Bayer

Venture capital firm, small business lender and impact investor Advantage Capital has hired Jeff Grass to lead all corporate communications and marketing activities as Vice President of Communications and Stakeholder Engagement.

Key Points: 
  • Venture capital firm, small business lender and impact investor Advantage Capital has hired Jeff Grass to lead all corporate communications and marketing activities as Vice President of Communications and Stakeholder Engagement.
  • Grass role at Advantage Capital builds upon his accomplished career in communicationsincluding promoting and protecting some of the most iconic brands in America and helping drive global growth for industry-leading products.
  • Prior to joining Advantage Capital, he served as a Global Director of Communications at Bayer Corporation where he led corporate and product communications, issues and reputation management, and internal communications for the multinational life science companys digital farming division.
  • Advantage Capital provides financing to established and emerging companies located in communities underserved by conventional sources of capital.